NEA 15 GP, LLC
CIK 1640033 · last filed 2025-10-06
NEA 15 GP, LLC is a corporate insider who has filed 15 SEC Form 4 insider transactions across 8 companies since 2016. The most recent filing, for BHG, was dated Oct 6, 2025. Across all open-market trades the lifetime net is −$87.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.32B across reported positions. The firm reports its address in Timonium, MD. 60 SEC filings were submitted jointly with NEA Partners 15, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IONQ.WS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 600
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 1,960,591 | $16.35 | $32.06M | -$1.9K | 2 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 1 | 2024-10-03 |
| IONQ.WS | 10%+ Owner | 26,306,693 | $33.55 | $882.59M | -$136.59M | 1 | 2022-05-31 |
| HOOD | Director | 23,822,908 | $101.93 | $2.43B | $0 | 1 | 2022-05-04 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 1,939,841 | $4.96 | $9.62M | $0 | 1 | 2021-06-10 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,437,689 | $4.00 | $9.75M | $12.00M | 1 | 2020-07-28 |
| ARDX | 10%+ Owner | 3,482,186 | $3.13 | $10.90M | $23.33M | 4 | 2019-12-09 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 2,089,604 | $15.00 | $31.34M | $14.02M | 4 | 2018-12-21 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Mixed | −1,381,700 | $5 | EDGAR |
| 2024-10-03 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2022-05-31 | IONQ.WS | Sell (S) | −23,383,728 | -$136.59M | EDGAR |
| 2022-05-04 | HOOD | Other (J) | −142,937,454 | $0 | EDGAR |
| 2021-06-30 | NeueHealth, Inc. (BHG) Delisted | Conv (C) | +63,676,587 | $0 | EDGAR |
| 2021-06-10 | Desktop Metal, Inc. (DM) Delisted | Other (J) | −18,000,000 | $0 | EDGAR |
| 2020-07-28 | Inozyme Pharma, Inc. (INZY) Delisted | Mixed | +7,313,067 | $12.00M | EDGAR |
| 2019-12-09 | ARDX | Grant (A) | +400,000 | $2.50M | EDGAR |
| 2018-12-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +2,000,000 | $3.10M | EDGAR |
| 2018-11-19 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +4,800,000 | $8.95M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.